Anaconda Biomed S.L.
PrivateLast Round
VC Round
Sep 23, 2026
Total Funding Raised
$50.56M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Anaconda Biomed S.L. is a medical technology company that develops next-generation thrombectomy systems for the treatment of ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anaconda Biomed S.L. Comparables
Compare Anaconda Biomed S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vesalio | 92% | |
| Perfuze | 91% | |
| Ceretrieve | 90% |
Anaconda Biomed S.L. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2026 | ||||
| VC Round | Jan 9, 2025 | ||||
| Debt | Oct 6, 2021 | ||||
| Series B | Dec 4, 2019 | ||||
| Grant | Aug 9, 2018 | ||||
Series A | May 22, 2017 |
Anaconda Biomed S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | VC Round, Series B |
| Omega Funds | Series B, Series A, VC Round |
| CDTI Innvierte | VC Round |
| Ysios Capital | VC Round, Series B, Series A |
| Innogest Capital | Series B, Series A |
| EIT Health | Grant |
| European Investment Bank Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
$56M round led by Omega Funds.
- Jun 11, 2025
Dr. Charles 'Chuck' Carignan appointed Chairman of the board.
Recent news
Latest coverage and updates
- expands_facilitiesSep 23, 2026
Anaconda expands facilities to Barcelona, Spain, Southern Europe, Europe.
- is_developingSep 23, 2026
Anaconda is developing portfolio of products built on this technology on Jul 1st '26.
- receives_financingSep 23, 2026
Anaconda closes $56M financing round in Spain and California on Sep 23rd '26
Anaconda Biomed S.L. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anaconda Biomed S.L.'s valuation, stock price, and market status.
Is Anaconda Biomed S.L. a public or private company?
Anaconda Biomed S.L. is a private company.
What is the current stock price of Anaconda Biomed S.L.?
Anaconda Biomed S.L. is a private company, so its shares have no public market price. Caplight tracks Anaconda Biomed S.L.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anaconda Biomed S.L. worth (valuation)?
Valuation information for Anaconda Biomed S.L. is not publicly available.
Can I buy Anaconda Biomed S.L. stock?
Anaconda Biomed S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anaconda Biomed S.L.'s last funding round?
Anaconda Biomed S.L.'s most recent funding round was VC Round on September 23, 2026.
Who are the main investors in Anaconda Biomed S.L.?
Key investors in Anaconda Biomed S.L. include Asabys Partners, Omega Funds, Ysios Capital, Innogest Capital.
Will Anaconda Biomed S.L. IPO soon?
No public IPO plans have been announced for Anaconda Biomed S.L..
How can I track Anaconda Biomed S.L. secondary market activity?
Caplight tracks bids, offers, and trades in Anaconda Biomed S.L.'s shares on secondary markets.